43 related articles for article (PubMed ID: 34465534)
1. Association Between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women.
Motoki AH; Buttros DAB; Gaspar AL; Almeida-Filho BS; Carvalho-Pessoa E; Vespoli HDL; Nahas-Neto J; Nahas EAP
Clin Breast Cancer; 2022 Feb; 22(2):e253-e261. PubMed ID: 34465534
[TBL] [Abstract][Full Text] [Related]
2. Association between Metabolic Syndrome Risk Factors and Immunohistochemical Profile in Women with Breast Cancer.
Danesh H; Anbiaei R; Ziamajidi N; Farhadian M; Barartabar Z; Abbasalipourkabir R
Iran J Med Sci; 2023 Sep; 48(5):456-464. PubMed ID: 37786471
[TBL] [Abstract][Full Text] [Related]
3. The 60- and 70-kDa heat-shock proteins and their correlation with cardiovascular risk factors in postmenopausal women with metabolic syndrome.
Nahas EA; Nahas-Neto J; Orsatti CL; Tardivo AP; Uemura G; Peraçoli MT; Witkin SS
Cell Stress Chaperones; 2014 Jul; 19(4):559-68. PubMed ID: 24327239
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Toll-Like receptor 2 and 4 RNA expression and the cytokine profile in postmenopausal women with metabolic syndrome.
Orsatti CL; Petri Nahas EA; Nahas-Neto J; Orsatti FL; Giorgi VI; Witkin SS
PLoS One; 2014; 9(10):e109259. PubMed ID: 25329057
[TBL] [Abstract][Full Text] [Related]
5. Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women.
Phipps AI; Malone KE; Porter PL; Daling JR; Li CI
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2078-86. PubMed ID: 18664548
[TBL] [Abstract][Full Text] [Related]
6. Effect of exercise on metabolic syndrome in black women by family history and predicted risk of breast cancer: The FIERCE Study.
Dash C; Taylor TR; Makambi KH; Hicks J; Hagberg JM; Adams-Campbell LL
Cancer; 2018 Aug; 124(16):3355-3363. PubMed ID: 29975403
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and breast cancer: a dangerous association for postmenopausal women.
Palmiero P; Maiello M; Cecere A; Ciccone MM
Acta Biomed; 2021 Sep; 92(4):e2021177. PubMed ID: 34487081
[TBL] [Abstract][Full Text] [Related]
8. Central obesity, body mass index, metabolic syndrome and mortality in Mediterranean breast cancer patients.
Crispo A; Augustin LSA; Luongo A; Calderaio C; Breda J; Coluccia S; Calabrese A; Marrazzo V; Giannatiempo R; Trasacco P; Palumbo E; Vitale S; Porciello G; Di Gennaro P; Caputo R; Buono G; Vernieri C; Schettini F; Grimaldi M; Nocerino F; Celentano E; Amore A; Giuliano M; De Placido P; De Angelis C; Bianco R; De Laurentiis M; La Vecchia C; Arpino G
Sci Rep; 2023 Dec; 13(1):21208. PubMed ID: 38040773
[TBL] [Abstract][Full Text] [Related]
9. Changes in metabolic syndrome and the risk of breast and endometrial cancer according to menopause in Korean women.
Tran TXM; Kim S; Park B
Epidemiol Health; 2023; 45():e2023049. PubMed ID: 37139668
[TBL] [Abstract][Full Text] [Related]
10. The association between mammographic density and breast cancer molecular subtypes: a systematic review and meta-analysis.
Bai S; Song D; Chen M; Lai X; Xu J; Dong F
Clin Radiol; 2023 Aug; 78(8):622-632. PubMed ID: 37230842
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women's Health Initiative.
Chlebowski RT; Aragaki AK; Pan K; Simon MS; Neuhouser ML; Haque R; Rohan TE; Wactawski-Wende J; Orchard TS; Mortimer JE; Lane D; Kaunitz AM; Desai P; Wild RA; Barac A; Manson JE
Cancer; 2024 May; ():. PubMed ID: 38736319
[TBL] [Abstract][Full Text] [Related]
12. High risk for cardiovascular disease in postmenopausal breast cancer survivors.
Buttros DAB; Branco MT; Orsatti CL; Almeida-Filho BS; Nahas-Neto J; Nahas EAP
Menopause; 2019 Sep; 26(9):1024-1030. PubMed ID: 31453965
[TBL] [Abstract][Full Text] [Related]
13. Association of lipid profile biomarkers with breast cancer by molecular subtype: analysis of the MEND study.
Gupta A; Saraiya V; Deveaux A; Oyekunle T; Jackson KD; Salako O; Daramola A; Hall A; Alatise O; Ogun G; Adeniyi A; Ayandipo O; Olajide T; Olasehinde O; Arowolo O; Adisa A; Afuwape O; Olusanya A; Adegoke A; Tollefsbol TO; Arnett D; Muehlbauer MJ; Newgard CB; ; Akinyemiju T
Sci Rep; 2022 Jun; 12(1):10631. PubMed ID: 35739205
[TBL] [Abstract][Full Text] [Related]
14. Body size and the risk of postmenopausal breast cancer subtypes in the California Teachers Study cohort.
Canchola AJ; Anton-Culver H; Bernstein L; Clarke CA; Henderson K; Ma H; Ursin G; Horn-Ross PL
Cancer Causes Control; 2012 Jan; ():. PubMed ID: 22286371
[TBL] [Abstract][Full Text] [Related]
15. Lipid profile in breast cancer: From signaling pathways to treatment strategies.
Taborda Ribas H; Sogayar MC; Dolga AM; Winnischofer SMB; Trombetta-Lima M
Biochimie; 2024 Apr; 219():118-129. PubMed ID: 37993054
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical and Clinicopathological Characteristics of Invasive Breast Carcinoma in Nigeria.
Wemimo RM; Eziagu UB; Sulaiman OA; Abiodun AE; Idowu NA; Ayinde AA; Taiwo AA
Oman Med J; 2023 Sep; 38(5):e548. PubMed ID: 38225996
[TBL] [Abstract][Full Text] [Related]
17. Serum Endocan Levels in Postmenopausal Women with Metabolic Syndrome.
Klisic A; Kotur-Stevuljevic J; Patoulias D; Ninic A
Metab Syndr Relat Disord; 2023 Dec; 21(10):561-566. PubMed ID: 37669459
[No Abstract] [Full Text] [Related]
18. Increased survival of women with luminal breast cancer and progesterone receptor immunohistochemical expression of greater than 10.
Lehrer S; Rheinstein PH
Cancer; 2023 Jul; 129(13):2103-2104. PubMed ID: 37106560
[No Abstract] [Full Text] [Related]
19. Reply to "Increased survival of women with luminal breast cancer and progesterone receptor immunohistochemical expression of greater than 10%".
Lashen AG; Toss MS; Rakha EA
Cancer; 2023 Jul; 129(13):2105. PubMed ID: 37106558
[No Abstract] [Full Text] [Related]
20. A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy.
Stebbing J; Sharma A; North B; Athersuch TJ; Zebrowski A; Pchejetski D; Coombes RC; Nicholson JK; Keun HC
Ann Oncol; 2012 Apr; 23(4):860-6. PubMed ID: 21821546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
